• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童髓母细胞瘤的复发。

Recurrence in childhood medulloblastoma.

机构信息

Department of Neuroradiology, Reference Center for Neuroradiology, University of Würzburg, Josef-Schneider-Str.11, 97080 Würzburg, Germany.

出版信息

J Neurooncol. 2011 Jul;103(3):705-11. doi: 10.1007/s11060-010-0452-x. Epub 2010 Nov 11.

DOI:10.1007/s11060-010-0452-x
PMID:21069427
Abstract

Thirty-eight consecutive children treated according to the HIT2000 and HIT91 studies for medulloblastoma who suffered 40 recurrence events were identified from a neuroradiological database. Relapse was associated with younger median age compared with all children treated on HIT2000. Eight patients relapsed with isolated local recurrence. There was no correlation with incomplete surgical removal or violation of the respective treatment protocol. Four patients were younger than 4 years at time of initial presentation and thus were not treated primarily with radiotherapy, suggesting that delayed radiotherapy might be a contributing factor. Meningeal dissemination was present in 32 events; 16 were located in the frontal region, 8 of which were isolated nodular frontal and frontobasal meningeal disease. Circumscribed meningeal recurrences were associated with better overall survival (OS) compared with diffuse, widespread recurrences. Isolated frontobasal meningeal relapses are a well-known phenomenon in medulloblastomas even years after treatment and have been correlated to an underdose of radiation in many literature reports. However, in our patients there was no correlation to possible treatment violations, indicating that inadequate radiation dose to the frontobasal region was unlikely to be a causative factor. Surgical technique varied due to the multicentric nature of our study, so position during surgery was not recognized as a predisposing factor for frontobasal recurrence.

摘要

从神经放射学数据库中确定了 38 名连续接受 HIT2000 和 HIT91 研究治疗的髓母细胞瘤儿童,这些儿童发生了 40 次复发事件。与接受 HIT2000 治疗的所有儿童相比,复发与更年轻的中位年龄相关。8 例患者发生孤立局部复发。与不完全手术切除或违反各自治疗方案无关。4 名患者在初次就诊时年龄小于 4 岁,因此未接受主要放疗,表明放疗延迟可能是一个促成因素。32 次事件中有脑膜播散;16 例位于额叶,其中 8 例为孤立性结节状额叶和额底脑膜疾病。局限性脑膜复发与总体生存(OS)相关,与弥漫性、广泛复发相比。孤立性额底脑膜复发是髓母细胞瘤治疗后多年的一种众所周知的现象,在许多文献报告中与放疗剂量不足有关。然而,在我们的患者中,与可能的治疗违规无关,表明额底区域的辐射剂量不足不太可能是一个致病因素。由于我们的研究是多中心的,因此手术技术有所不同,因此手术期间的位置未被认为是额底复发的诱发因素。

相似文献

1
Recurrence in childhood medulloblastoma.儿童髓母细胞瘤的复发。
J Neurooncol. 2011 Jul;103(3):705-11. doi: 10.1007/s11060-010-0452-x. Epub 2010 Nov 11.
2
Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.成髓细胞瘤成人和儿童的治疗结果:美国国立癌症研究所、开罗大学的经验
J Egypt Natl Canc Inst. 2008 Jun;20(2):175-86.
3
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.在多学科治疗方案内治疗促结缔组织增生性髓母细胞瘤的结果和预后因素。
BMC Cancer. 2010 Aug 23;10:450. doi: 10.1186/1471-2407-10-450.
4
Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.推迟并非取消:颅脊柱放射治疗在复发性婴儿髓母细胞瘤治疗中的作用——HIT-REZ 1997 年和 2005 年研究的经验。
Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1019-24. doi: 10.1016/j.ijrobp.2014.01.013.
5
Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.髓母细胞瘤的继发表现:66例患者的转移和局部复发
Acta Neurochir (Wien). 1995;136(3-4):117-26. doi: 10.1007/BF01410612.
6
Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.髓母细胞瘤的术后放射治疗——额下区域高复发率
J Neurooncol. 2002 May;58(1):77-85. doi: 10.1023/a:1015865614640.
7
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.采用术后化疗及延迟放疗治疗儿童早期髓母细胞瘤。
Neuro Oncol. 2009 Apr;11(2):201-10. doi: 10.1215/15228517-2008-084. Epub 2008 Sep 25.
8
Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.髓母细胞瘤播散性复发的多因素分析及其全脑脊髓照射时间参数的估计
Radiat Med. 2003 Jan-Feb;21(1):37-45.
9
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.时间、模式和髓母细胞瘤复发的结果及其与诊断和治疗时肿瘤生物学的关系:一项多中心队列研究。
Lancet Child Adolesc Health. 2020 Dec;4(12):865-874. doi: 10.1016/S2352-4642(20)30246-7. Epub 2020 Oct 22.
10
Medulloblastoma in adulthood: prognostic factors influencing survival and recurrence.成人髓母细胞瘤:影响生存和复发的预后因素
Acta Neurochir (Wien). 1994;127(1-2):65-8. doi: 10.1007/BF01808549.

引用本文的文献

1
Role of Radiotherapy in Patients With Relapsed Medulloblastoma.放射治疗在复发性髓母细胞瘤患者中的作用
Brain Tumor Res Treat. 2023 Jan;11(1):22-27. doi: 10.14791/btrt.2022.0033.
2
A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma.髓母细胞瘤生物学驱动及广谱治疗方案的现状与未来:一项全面综述
Cureus. 2022 Mar 24;14(3):e23447. doi: 10.7759/cureus.23447. eCollection 2022 Mar.
3
Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.

本文引用的文献

1
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.前瞻性随机多中心试验HIT'91中治疗的髓母细胞瘤患儿的长期预后及临床预后因素
Eur J Cancer. 2009 May;45(7):1209-1217. doi: 10.1016/j.ejca.2009.01.015. Epub 2009 Feb 26.
2
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.在不进行化疗的标准风险髓母细胞瘤中采用适形放疗、缩小推量体积、超分割放疗及在线质量控制:法国M-SFOP 98方案的结果
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):711-6. doi: 10.1016/j.ijrobp.2005.03.031. Epub 2005 May 31.
3
经组织学和DNA甲基化分析证实,18年后4型髓母细胞瘤复发。
Childs Nerv Syst. 2019 Jun;35(6):1029-1033. doi: 10.1007/s00381-019-04086-3. Epub 2019 Feb 22.
4
Subfrontal recurrence after cerebellar medulloblastoma resection without local relapse: case-based update.小脑髓母细胞瘤切除术后无局部复发的额叶下复发:基于病例的最新进展
Childs Nerv Syst. 2018 Sep;34(9):1619-1626. doi: 10.1007/s00381-018-3869-8. Epub 2018 Jun 23.
5
Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.扩散加权成像在小儿中枢神经系统胚胎性肿瘤监测中的附加价值
Oncotarget. 2017 Jul 25;8(36):60401-60413. doi: 10.18632/oncotarget.19553. eCollection 2017 Sep 1.
6
Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model.帕比司他是一种组蛋白去乙酰化酶抑制剂,可抑制髓母细胞瘤动物模型中的软脑膜播散。
Oncotarget. 2017 May 24;8(34):56747-56757. doi: 10.18632/oncotarget.18132. eCollection 2017 Aug 22.
7
Evidence of high mortality in long term survivors of childhood medulloblastoma.儿童髓母细胞瘤长期幸存者的高死亡率证据。
J Neurooncol. 2015 Apr;122(2):321-7. doi: 10.1007/s11060-014-1712-y. Epub 2015 Jan 4.
8
Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors.髓母细胞瘤和颅内原始神经外胚层肿瘤的管理进展
F1000Prime Rep. 2014 Jul 8;6:56. doi: 10.12703/P6-56. eCollection 2014.
9
Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.儿童髓母细胞瘤海马保留放疗:治疗边缘和治疗技术的影响。
Neuro Oncol. 2014 Apr;16(4):594-602. doi: 10.1093/neuonc/not225. Epub 2013 Dec 9.
10
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.各髓母细胞瘤亚组的复发模式:一项综合临床和分子分析。
Lancet Oncol. 2013 Nov;14(12):1200-7. doi: 10.1016/S1470-2045(13)70449-2. Epub 2013 Oct 17.
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.仅通过术后化疗治疗儿童早期髓母细胞瘤。
N Engl J Med. 2005 Mar 10;352(10):978-86. doi: 10.1056/NEJMoa042176.
4
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.在国际儿科肿瘤学会/英国儿童癌症研究组针对M0 - M1期髓母细胞瘤的放疗前化疗的PNET - 3研究中,放疗参数对治疗结果的影响
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1184-93. doi: 10.1016/j.ijrobp.2003.08.010.
5
Medulloblastoma: present concepts of stratification into risk groups.髓母细胞瘤:当前将其分层为风险组的概念
Pediatr Neurosurg. 2003 Jul;39(2):60-7. doi: 10.1159/000071316.
6
Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.髓母细胞瘤播散性复发的多因素分析及其全脑脊髓照射时间参数的估计
Radiat Med. 2003 Jan-Feb;21(1):37-45.
7
Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.髓母细胞瘤的术后放射治疗——额下区域高复发率
J Neurooncol. 2002 May;58(1):77-85. doi: 10.1023/a:1015865614640.
8
Population-based epidemiologic data on brain tumors in German children.基于德国儿童脑肿瘤的人群流行病学数据。
Cancer. 2001 Dec 15;92(12):3155-64. doi: 10.1002/1097-0142(20011215)92:12<3155::aid-cncr10158>3.0.co;2-c.
9
Prognostic factors for medulloblastoma.髓母细胞瘤的预后因素。
Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):573-84. doi: 10.1016/s0360-3016(00)00431-4.
10
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.儿童髓母细胞瘤治疗中,术前新辅助化疗后放疗与直接放疗后维持化疗的比较:德国前瞻性随机试验HIT '91的结果
Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):269-79. doi: 10.1016/s0360-3016(99)00369-7.